seen from United Kingdom
seen from China
seen from China
seen from Guam
seen from China
seen from Malaysia
seen from Germany
seen from Russia
seen from Malaysia
seen from Ireland
seen from Malaysia
seen from South Korea
seen from United States
seen from United States
seen from Spain
seen from Greece
seen from United Kingdom
seen from Italy
seen from France
seen from United Arab Emirates
Top Pharma News of the Week
All The Most Important Pharmaceutical News Stories Of The Week – February 2018 – Week #1 Amgen Receives CHMP Positive Opinion to Add Updated Overall Survival Data to KYPROLIS® (carfilzomib) Label
January 30, 2018
Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a label variation…
View On WordPress
Bandage Turns Green to Signal Infection
Bandage Turns Green to Signal Infection
Image Courtesy: link: http://www.gadgetpronew.com/2015/12/smart-bandage-signals-infection-by.html%3Fm%3D0 author: gadgetpronew.com description: Smart Bandage Signals C O N T E N T S: KEY TOPICS Bacterial infection is a fairly common and potentially dangerous complication of wound healing, but a new “intelligent” dressing that turns fluorescent green to signal the onset of an infection could…
View On WordPress
Antibiotic Resistance in the US
Antibiotic Resistance in the US
Centers for Disease Control and Prevention (CDC) ANTIBIOTIC RESISTANCE THREATS in the United States
2013
Facts about Antibiotic Resistance
Antibiotic resistance has been called one of the world’s most pressing public health problems.
Every time a person takes antibiotics, sensitive bacteria are killed, but resistant ones may be left to grow and multiply.
Repeated and improper uses of antibiotics…
View On WordPress
Drug Safety Communication - Dose Confusion and Medication Errors
Drug Safety Communication – Dose Confusion and Medication Errors
Avycaz (ceftazidime and avibactam)
[pullquote align=”right”][adrotate banner=”7″][/pullquote]
Antibacterial Drug for Risk of Dosing Errors
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and avibactam) due to confusion about the drug strength displayed on the vial and carton labels. Avycaz was initially approved…
View On WordPress
